1 |
Relationship of VMH, Amygdala, and Taste Under Two Feeding SchedulesAngelo, Winifred Lee 01 January 1970 (has links)
No description available.
|
2 |
Physiological Responding in Anhedonic and Perceptually Aberrant College StudentsStauffer, Kathryn Elizabeth 01 January 1991 (has links)
No description available.
|
3 |
Possible Regulatory Effects of Coalition Computations on the Mu RhythmGagnon, Kyle Timothy 01 January 2010 (has links)
No description available.
|
4 |
Electroencephalographic Spectra Preceding Spontaneous BlinksEppler, Marion Auerswald 01 January 1984 (has links)
No description available.
|
5 |
Humor Appreciation and the Right HemisphereWaller, Melissa Beth 01 January 1992 (has links)
No description available.
|
6 |
"The Chills" as a Psychological Response: Affective Composition, Trait Antecedents, and Factor StructureMaruskin, Laura Anne 01 January 2010 (has links)
No description available.
|
7 |
Analyzing Anticipatory Muscle Tensing as a Measure of Prospective ActionReardon, Kristin Michelle 01 January 2009 (has links)
No description available.
|
8 |
Pain Perception and Perspective Taking in Spinal Cord Injury PatientsDuckett, Caitlin J. 01 January 2014 (has links)
No description available.
|
9 |
The Effects of Intranasal Orexin-A on Mk-801-Induced Attentional Deficits: Addressing Cognitive Impairment in An Nmda Receptor Hypofunction Model of SchizophreniaManess, Eden Blake-Lea 23 August 2017 (has links)
Schizophrenia (SZ) is a debilitating condition wherein those afflicted experience positive symptoms, including hallucinations and delusions, as well as negative symptoms, including alterations of processing affecting cognition and social interactions. The NMDA receptor hypofunction model of SZ asserts that a reduction in hippocampal NMDA receptor input produces the pathology of this disorder, promoting excessive frontocortical excitatory neurotransmission – particularly overstimulation of basal forebrain cholinergic neurons – that ultimately impairs cognitive and sensorimotor processes. Orexin-A (OxA), a neuropeptide principally involved in wakefulness and appetitive behaviors, has been shown to demonstrate cognitive-enhancing qualities in models of psychiatric and neurodegenerative illness. In the present study, the effects of OxA on attentional performance were examined in a NMDA receptor antagonist model of SZ. Male Fischer 344 Brown Norway F1 Hybrid rats (N = 12) received both intraperitoneal injections of MK-801 and intranasal administration of OxA prior to placement in a sustained attention task requiring differentiation between signal trials (500, 100, and 25ms illumination of a central panel light) and non-signal trials (no light illumination). Overall, it was shown that the highest dose of OxA exacerbated MK-801-induced attentional deficits. While the small OxA concentration slightly protected against impairments in the correct rejection of the signal and increased omission rates at the low dose of MK-801, this excitatory neuromodulator was largely unable to improve performance in the attention task. These findings suggest that, in a state of cortical hyperexcitation like what is observed both in SZ and following NMDA receptor antagonism, the introduction of pharmacotherapies augmenting activity at the orexinergic system further exacerbates existing cognitive dysfunction in lieu of alleviating these symptoms.
|
10 |
Suppression of the Galvanic Skin Response by Cognitively Mediated BehaviorHughes, William Gresby 01 January 1970 (has links) (PDF)
No description available.
|
Page generated in 0.0756 seconds